COMMUNIQUÉS West-GlobeNewswire

New U.S. Patent Issuance Granted to AXIM® Biotechnologies for Oral Care Composition Containing Cannabinoids
29/01/2019
NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the United States Patent [...]
Canada's Marijuana Retail Landscape and Some of the Biggest Players Involved
29/01/2019
VANCOUVER, British Columbia, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Following the 3-month anniversary of marijuana’s legalization in Canada, analysts and consumers alike are wondering what’s next for Canada’s marijuana [...]
Orion Biotechnology Canada report that IND- enabling studies evaluating the safety of their OB-002H microbicide gel have shown an excellent mucosal safety profile
29/01/2019
OTTAWA, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data evaluating the safety of OB-002H (5P12-RANTES) which is being [...]
Arch Biopartners Closes Convertible Note Financing
29/01/2019
TORONTO, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has closed the non-brokered, unsecured convertible note (“Note”) financing [...]
Marrone Bio Innovations to Host Virtual Roadshow Webinar on February 12th at 8:30 a.m. Pacific Time
29/01/2019
DAVIS, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), an international leader in smart biopesticide and plant health solutions, today announced that it [...]
Menlo Therapeutics Announces Late-Breaking Oral Presentation at the American Academy of Dermatology Annual Meeting
29/01/2019
Results from the Phase 2 Clinical Trial of Serlopitant to Treat Pruritus with Psoriasis to be Presented on March 2, 2019 REDWOOD CITY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a [...]
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day
29/01/2019
LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines, today [...]
OLAH Healthcare Technology names Gregory Miller as Chief Executive Officer
29/01/2019
COLUMBUS, Ohio, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Tim Vogel, chairman of the Board of Directors of OLAH Healthcare Technology, announced the appointment of Gregory Miller as OLAH’s new chief executive officer effective [...]
Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting
29/01/2019
Bermekimab Rapidly Treats Atopic Dermatitis While Reducing Itch and Pain AUSTIN, Texas, Jan. 29, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that findings from its open label, multicenter study [...]
Extendicare Announces Timing of 2018 Fourth Quarter and Year End Results and Conference Call
29/01/2019
MARKHAM, Ontario, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter and year ended [...]
Momenta Pharmaceuticals Announces First Subject Dosed in Phase 1/2 Clinical Trial of M254, Hypersialylated Immunoglobulin G
29/01/2019
CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Oryzon to present at upcoming international conferences
29/01/2019
21 st Annual BIO CEO & Investor Conference 2019 in New York, USA 12 th Annual European Life Sciences CEO Forum in Zurich, Switzerland 2019 BioCapital Europe in Amsterdam, The Netherlands 31 st Annual ROTH Conference [...]
Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism
29/01/2019
-- 82% (9 of 11) response rate in patients with cholinergic urticaria -- -- 70% (7 of 10) response rate in patients with symptomatic dermographism -- REDWOOD CITY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Allakos Inc [...]
Samumed to Present Novel Biological Targets of SM04690 for Treatment of Knee Osteoarthritis
29/01/2019
Study results highlight novel drug discovery targets for the treatment of knee osteoarthritis Company to present data in late-breaking poster at Orthopaedic Research Society (ORS) 2019 Annual Meeting SAN DIEGO, Jan. 29 [...]
Spero Therapeutics Announces Initiation of SPR720 Phase 1 Clinical Trial
29/01/2019
CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]
scPharmaceuticals Inc. Announces Development Agreement with West Pharmaceutical Services for Next-Generation FUROSCIX® On-Body Infusor
29/01/2019
Advancing FUROSCIX ® with the SmartDose ® Drug Delivery System Forecast 2018 year-end cash of $82 - $87 million and 2019 expenditures of $8 - $10 million per quarter BURLINGTON, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- [...]
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder
29/01/2019
Approval allows BrainsWay’s Deep TMS System to be marketed throughout Japan JERUSALEM, Jan. 29, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN) , a global leader in the advanced non-invasive treatment of brain [...]
Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria
29/01/2019
GAITHERSBURG, Md., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced results of its recently completed HepTcell Phase 1 clinical trial will be [...]
Precipio Gains Recognition on NY Radio Station WHPC Show “My Hometown” As Innovator Battling Cancer Misdiagnosis
29/01/2019
CEO Ilan Danieli discusses the importance of obtaining an accurate diagnosis, and the challenges patients and physicians face NEW HAVEN, Conn., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company [...]

Pages